Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: RXST

RxSight, Inc.

Healthcare | Medical - Devices

No licensed closing price on file for RXST. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (TTM)$-1.13

RxSight, Inc. (NASDAQ: RXST) is a medical device company. Figures from SEC EDGAR; updated 2026-10-20 01:50 UTC.

What RxSight, Inc. does

RxSight, Inc. is a medical technology company that develops and commercializes the RxSight Light Adjustable Lens system for cataract surgery. The system consists of a special intraocular lens made from photosensitive silicone material and a light delivery device that allows surgeons to adjust a patient's vision after surgery rather than relying on preset lens power before the procedure. Unlike conventional premium intraocular lenses that cannot be modified after implantation, the RxSight system enables post-surgical customization of vision in precise increments.

Summarized from RxSight, Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Pre-revenue, development-stage company: standard profitability ratios (P/E, EV/EBITDA, ROE) do not apply yet because there are no earnings. Watch cash, cash runway, net loss, R&D spend and share dilution instead.

Key facts

Valuation
EPS (TTM)$-1.13

Revenue, margins & earnings

FY2021: net loss $49M on revenue $23M$23MFY2021FY2022: net loss $67M on revenue $49M$49MFY2022FY2023: net loss $49M on revenue $89M$89MFY2023FY2024: net loss $27M on revenue $140M$140MFY2024FY2025: net loss $39M on revenue $134M$134MFY2025
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
  • Net loss year
Annual revenue; bands show net, operating, gross margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-09-16
  • 2026-09-16See remarksStock Option (right to buy)Option exercise-35,168—
  • 2026-09-16See remarksOption exercise35,168$152.6K
  • 2026-09-09Chief Operating OfficerStock Option (right to buy)Returned to company-92,200—
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does RxSight, Inc. do?

RxSight, Inc. is a medical device company, listed on NASDAQ as RXST.

When did RXST last file with the SEC?

RxSight, Inc.'s most recent SEC filing on record is a 8-K filed 2026-07-06. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 01:50 UTC. This page is also available as JSON at /api/data?ticker=RXST and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for RXST and 5,000+ tickers.

Create a free account — keep RXST
For your agent
GET /api/data?ticker=RXST

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt